Cargando…
Targeting iron metabolism in cancer therapy
Iron is a critical component of many cellular functions including DNA replication and repair, and it is essential for cell vitality. As an essential element, iron is critical for maintaining human health. However, excess iron can be highly toxic, resulting in oxidative DNA damage. Many studies have...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344014/ https://www.ncbi.nlm.nih.gov/pubmed/34373750 http://dx.doi.org/10.7150/thno.59092 |
_version_ | 1783734408607432704 |
---|---|
author | Morales, Michael Xue, Xiang |
author_facet | Morales, Michael Xue, Xiang |
author_sort | Morales, Michael |
collection | PubMed |
description | Iron is a critical component of many cellular functions including DNA replication and repair, and it is essential for cell vitality. As an essential element, iron is critical for maintaining human health. However, excess iron can be highly toxic, resulting in oxidative DNA damage. Many studies have observed significant associations between iron and cancer, and the association appears to be more than just coincidental. The chief characteristic of cancers, hyper-proliferation, makes them even more dependent on iron than normal cells. Cancer therapeutics are becoming as diverse as the disease itself. Targeting iron metabolism in cancer cells is an emerging, formidable field of therapeutics. It is a strategy that is highly diverse with regard to specific targets and the various ways to reach them. This review will discuss the importance of iron metabolism in cancer and highlight the ways in which it is being explored as the medicine of tomorrow. |
format | Online Article Text |
id | pubmed-8344014 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-83440142021-08-08 Targeting iron metabolism in cancer therapy Morales, Michael Xue, Xiang Theranostics Review Iron is a critical component of many cellular functions including DNA replication and repair, and it is essential for cell vitality. As an essential element, iron is critical for maintaining human health. However, excess iron can be highly toxic, resulting in oxidative DNA damage. Many studies have observed significant associations between iron and cancer, and the association appears to be more than just coincidental. The chief characteristic of cancers, hyper-proliferation, makes them even more dependent on iron than normal cells. Cancer therapeutics are becoming as diverse as the disease itself. Targeting iron metabolism in cancer cells is an emerging, formidable field of therapeutics. It is a strategy that is highly diverse with regard to specific targets and the various ways to reach them. This review will discuss the importance of iron metabolism in cancer and highlight the ways in which it is being explored as the medicine of tomorrow. Ivyspring International Publisher 2021-07-25 /pmc/articles/PMC8344014/ /pubmed/34373750 http://dx.doi.org/10.7150/thno.59092 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Review Morales, Michael Xue, Xiang Targeting iron metabolism in cancer therapy |
title | Targeting iron metabolism in cancer therapy |
title_full | Targeting iron metabolism in cancer therapy |
title_fullStr | Targeting iron metabolism in cancer therapy |
title_full_unstemmed | Targeting iron metabolism in cancer therapy |
title_short | Targeting iron metabolism in cancer therapy |
title_sort | targeting iron metabolism in cancer therapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344014/ https://www.ncbi.nlm.nih.gov/pubmed/34373750 http://dx.doi.org/10.7150/thno.59092 |
work_keys_str_mv | AT moralesmichael targetingironmetabolismincancertherapy AT xuexiang targetingironmetabolismincancertherapy |